Astellas

Silhouette of Businessman Entering Lit Door Passage in Darkness

Biotech

Astellas turns down option to license Taysha gene therapy—again

The biotech plans to advance the gene therapy into late-stage development, with the launch of a pivotal trial slated for this quarter.

Gabrielle Masson Oct 17, 2025 10:50am

RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am

Close-up of panning for gold

Astellas aims for CLDN18.2 gold with $1.34B licensing deal

May 29, 2025 7:30pm

Parachute over La Jolla California

J&J vet jumps to Affinia—Chutes & Ladders

Feb 7, 2025 8:30am

Board room C-suite meeting contract

Astellas fires CSO, chief manufacturing officer in shake-up

Feb 4, 2025 4:44am

Graphic image of an arrow nailing the bullseye of a target

Bayer’s hot flash drug hits goal in phase 3 breast cancer trial

Jan 9, 2025 7:40am